Algal Active Ingredients and Their Involvement in Managing Diabetic Mellitus

Area of Science:

• Marine biology
• Pharmacology
• Biochemistry

Background:

• Diabetes mellitus (DM) prevalence is increasing globally, impacting public health.
• Marine algae are a significant source for novel drug discovery.
• Seaweed contains bioactive compounds like polysaccharides, polyphenols, unsaturated fatty acids, and dietary fiber with unique biological activities.

Purpose of the Study:

• To review the effects and mechanisms of seaweed components on glucose and lipid metabolism disorders.
• To focus on the hypoglycemic effects of active seaweed substances.
• To provide a foundation for developing seaweed-derived hypoglycemic drugs.

Main Methods:

• Literature review of research on marine algae and their active substances.
• Analysis of the types, structures, and compositions of seaweed.
• Examination of mechanisms related to glucose and lipid metabolism.

Main Results:

• Seaweed active substances exhibit unique biological activities relevant to metabolic disorders.
• Specific components like algal polysaccharides and polyphenols show potential for blood glucose reduction.
• The composition and structure of seaweed influence their efficacy.

Conclusions:

• Marine algae possess bioactive compounds that can inhibit glucose and lipid metabolism disorders.
• Further research into seaweed active substances can lead to the development of effective hypoglycemic agents.
• Seaweed represents a promising natural resource for managing diabetes.